Breast cancer in male veteran population: An analysis from VA cancer registry

Journal of Community and Supportive Oncology

Volumn 12, Issue 8, 2014, Pages 293-297

  Aggarwal, Anita ^a   Liu, Min Ling ^a   Krasnow, Steven H ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CARCINOMA; BREAST DISCHARGE; BREAST SARCOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FAMILY HISTORY; FOLLOW UP; GYNECOMASTIA; HUMAN; INTRADUCTAL CARCINOMA; MALE; MALE BREAST CANCER; MASTECTOMY; MEDICAL RECORD; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VETERAN;

EID: 84971014361     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0066     Document Type: Article

References (34)

1. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51-57.
2. American Cancer Society. Cancer Facts and Figures 2014. Atlanta, GA: American Cancer Society, 2014. http://www.cancer.org/cancer/breastcancerinmen/detailedguide/breast-cancer-in-men-key-statistics. Revised January 31, 2014. Accessed June 11, 2014.
3. American Cancer Society. Cancer Facts and Figures 2012. Atlanta, Ga: American Cancer Society, 2012.
4. Burstein HJ, Harris JR, Morrow M. Malignant tumors of the breast. In: DeVita VT Jr, Lawrence TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp 1401-46.
5. Ravandi-Kashani F, Hayes TG. Male breast cancer: a review of the literature. Eur J Cancer. 1998;34:1341-1347.
6. Giordano SH. A review of diagnosis and management of male breast cancer. Oncologist. 2005;10:471-479.
7. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Inntern Med. 2002;137:678-687.
8. Nahleh Z, Girnius S. Male breast cancer: a gender issue. Nat Clin Pract Oncol. 2003;3:428-437.
9. Howlander N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2009: Fast Stats. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975-2009-pops09/, 2012. Accessed June 10, 2014.
10. Ravdin PM, Cronin KA, Howlander N, et al. The decrease in breastcancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-1674.
11. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007;99:1335-1339.
12. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360:573-587.
13. Anderson JR. Alarming breast cancer rates among troops. USA Today. October 2, 2012.
14. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Onc. 2010;28:232-239.
15. Thota R, Subbiah S, Tashi T, Aldoss I. Breast cancer in female veteran population: Survival analysis from VA cancer registry. 2010 JCO abst 170.
16. Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in veterans affairs population: a comparative analysis. Cancer. 2007;109:1471-1477.
17. Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst. 2000;92:1126-1135.
18. Palli D, Masala G, Mariani-Constantini R, et al. A gene environment interaction between occupation and BRCA1/BRCA2 mutations in male breast cancer? Eur J Cancer. 2005;40:2472-2479.
19. Hansen J. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Int Med. 2000;37:349-352.
20. Ron E, Ikeda T, Preston DL, Tokuoka S. Male breast cancer amongst atomic bomb survivors. J Natl Cancer Inst. 2005;97:603-605.
21. Lowell DM, Martineau RG, Luria SB. Carcinoma of male breast following radiation. Cancer 1968;22:581-586. Renee: I think this has been written incorrectly; I found a similar citation in pubmed but not this one.
22. Sasco AJ, Lowenfels AB, Pasker-De Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published casecontrol studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538-549.
23. Evans GF, Anthony T, Turnage RH, et al. The diagnostic accuracy of mammography in evaluation of male breast disease. Am J Surg. 2001;181:96-100.
24. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595-604.
25. Landrum MB, Keating NL, Lamont EB, et al. Survival of older patients with cancer in Veterans Health Administration versus feefor service Medicare. J Clin Oncol. 2012;30:1072-1079.
26. Stalsberg H, Thomas DB, Rosenblatt KA, et al. Histological types and hormone receptors in breast cancer in men: a population based study in 282 United States men. Cancer Causes Control. 1993;4:143-151.
27. Dawson PJ, Paine TM, Wolman SR. Immunocytochemical characterization of male breast cancer. Mod Pathol. 1992;5:621-625.
28. Wick MR, Sayadi H, Ritter JH, Hill DA, Reddy VB, Gattuso P. Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma. Am J Clin Pathol. 1999;111:59-69.
29. Bloom KJ, Govil H, Gattuso P, Reddy V, Francescatti D. Status of HER-2 in male and female breast carcinoma. Am J Surg. 2001;182:389-392.
30. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med. 2003;127:36-41.
31. Blin N, Kardas I, Welter C, et al. Expression of the c-erbB2 protooncogene in male breast carcinoma: lack of prognostic significance. Oncology. 1993;50:408-411.
32. Leach IH, Ellis IO, Elston CW. c-erb-B-2 expression in male breast carcinoma. J Clin Pathol. 1992;45:942.
33. Rayson D, Erlichman C, Suman VJ, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:1947-1955.
34. Pich A, Margaria E, Chiusa L, et al. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Br J Cancer. 1999;79:959-964.